Author surname, year | Intervention type | Sex | Intervention phase | Intervention group | Control group | Statistical findings reported** | Crude RR (95% CI) calculated by reviewer** | ||
---|---|---|---|---|---|---|---|---|---|
 |  |  |  | Patients (n) | % screened | Patients (n) | % screened |  |  |
 |  |  | During | 4018 | 16.8% | 9068 | 13.2% |  |  |
 |  | F | Roll out | 5368 | 15.5% | 12124 | 13.7% | NR | 1.3 (1.2-1.4) |
Morgan[21] 2009 | Incentive | Â | Before | 2676 | 13.9% | 6077 | 13.0% | Â | Â |
 |  |  | During | 4190 | 4.2% | 8524 | 2.1% |  |  |
 |  | M | Roll out | 5588 | 3.4% | 11333 | 2.1% | p = 0.05A | 2.0 (1.6-2.5) |
 |  |  | Before | 2833 | 3.0% | 5529 | 1.7% |  |  |
Merritt[20] 2007 | Quality improvement program | F | Late-intervention | -* | 10.2%C | -* | -* | NR | 1.5B |
 |  |  | Before | -* | 6.7%C | -* | -* |  |  |
 |  | M | Late-intervention | -* | 6.3%C | -* | -* | NR | 1.4B |
 |  |  | Before | -* | 4.5%C | -* | -* |  |  |
 |  | F | During | -* | 146^ | -* | 138^ | NR | 1.1B, D |
Armstrong[14] 2010 | Doctor education | Â | Before | -* | 53^ | -* | 113^ | Â | Â |
 |  | M | During | -* | 16^ | -* | 10^ | NR | 1.6B, D |
 |  |  | Before | -* | 4^ | -* | 8^ |  |  |
Bilardi[16] 2009 | Patient education | F | During | 2002 | 6.4% | -* | -* | 1.0E | 1.0 (0.8-1.2) |
 |  |  | Before | 1548 | 6.3% | -* | -* |  |  |
 |  | M | During | 995 | 3.0% | -* | -* | 0.8E | 1.1 (0.7-2.0) |
 |  |  | Before | 752 | 2.7% | -* | -* |  |  |
Schafer[23] 2002, | Quality improvement program | F | During | 1092 | 43.8% | 1299 | 15.6% | p < 0.01F | 2.8 (2.4-3.2) |
Tebb[24] 2005 | Â | Â | Before | 80 | 5.0% | 86 | 14.0% | Â | Â |
 |  | M | During | 990 | 44.9% | 1024 | 15.1% | p < 0.01G | 3.0 (2.5-3.5) |
 |  |  | Before | 76 | 2.6% | 61 | 7.0% |  |  |